Contact

Intelligaine welcomes corrections, questions, and feedback about our coverage and resources on In Tellig a in E. If you’ve spotted an issue or have a suggestion, we want to hear from you.

For details on how we source information and our editorial approach, please see our about page; it explains how Intelligaine operates and how we handle corrections and disclosures — the full editorial approach is outlined on the about page.

We currently do not publish a direct email or contact form; check back for published channels or subscribe to updates listed on our /about/ page.

How to reach Intelligaine

At present we do not list a direct email or phone. The site can be reached through its published channels when available; please check our about page for the editorial contact pathways and correction policy — the about page explains how we handle inquiries and corrections.

We strive to maintain independence and accuracy. If you wish to suggest factual corrections, please reference the specific page and include supporting sources so we can verify and update records promptly.

If you arrived here from another resource and want to return to the main guide, you can continue exploring Intelligaine’s homepage for curated topics and links to our resources.

Short note on outreach

We invite corrections, source suggestions, and clarifying feedback. Since we currently do not publish a direct contact email or phone, the best way to follow our updates or reach us will be via the channels listed on the about page; please revisit /about/ for the latest contact options.

If you are searching for program listings or regional guidance on ibogaine, some external resources such as peer-reviewed databases and institutional repositories can be useful — institutional pages like those from major universities or national health agencies often summarize clinical and safety frameworks.